Valuation: CellaVision AB

Market Cap 3.15B 323M 284M 262M 242M 459M 30.97B 468M 1.22B 15.15B 1.21B 1.19B 52.61B P/E 2026 *
23.3x
P/E 2027 * 18.6x
Enterprise Value 2.93B 301M 264M 244M 226M 427M 28.86B 436M 1.14B 14.12B 1.13B 1.11B 49.02B EV / Sales 2026 *
3.87x
EV / Sales 2027 * 3.41x
Free-Float
83.08%
Yield 2026 *
2.08%
Yield 2027 * 2.42%
1 day-3.37%
1 week-3.65%
Current month-3.08%
1 month+2.80%
3 months-13.73%
6 months-14.40%
Current year-16.03%
1 week 132
Extreme 132
148
1 month 125
Extreme 125
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 62
Extreme 62
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 60 2022-05-10
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
Jun. 11Buy 760 0.0032%
Jun. 08Buy

Founder

33,000 0.1384%
Jun. 08Buy

Director

314 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-3.37%-3.65%-27.79%-30.53% 323M
-5.12%-3.97%-0.86%-28.80% 15.79B
-1.77%-4.99%+29.21%+88.65% 1.62B
+1.47%-5.12%-44.03%-79.48% 1.18B
-0.39%-1.74%-29.05%+31.73% 1.09B
+0.29%-3.35%-29.97%-54.68% 614M
-2.23%-9.38%-41.11%-58.26% 537M
+1.03%+0.75%+27.64%-52.83% 453M
-0.96%+1.47%-54.85%-59.56% 377M
-7.15%-8.20%+33.81% - 287M
Average -0.96%-2.88%-13.70%-27.08% 2.23B
Weighted average by Cap. +0.12%-3.74%-4.38%-22.35%

Financials

2026 *2027 *
Net sales 759M 77.96M 68.38M 63.13M 58.34M 111M 7.46B 113M 295M 3.65B 293M 286M 12.68B 849M 87.22M 76.5M 70.63M 65.27M 124M 8.35B 126M 330M 4.09B 328M 320M 14.19B
Net income 135M 13.88M 12.18M 11.24M 10.39M 19.69M 1.33B 20.09M 52.51M 651M 52.14M 51M 2.26B 173M 17.79M 15.61M 14.41M 13.32M 25.24M 1.7B 25.74M 67.31M 834M 66.83M 65.36M 2.89B
Net Debt -214M -22.03M -19.32M -17.84M -16.49M -31.25M -2.11B -31.87M -83.33M -1.03B -82.73M -80.92M -3.58B -251M -25.83M -22.65M -20.91M -19.33M -36.63M -2.47B -37.37M -97.69M -1.21B -96.99M -94.87M -4.2B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-07-08 SEK 132.00 -3.37% 32,326
26-07-07 SEK 136.60 -4.74% 39,551
26-07-06 SEK 143.40 -2.05% 18,390
26-07-03 SEK 146.40 +2.52% 29,129
26-07-02 SEK 142.80 +4.23% 20,770
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
132.00SEK
Average target price
168.75SEK
Spread / Average Target
+27.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock